Literature DB >> 17685879

Menstrual migraine: a review of hormonal causes, prophylaxis and treatment.

Avi Ashkenazi1, Stephen Silberstein.   

Abstract

Migraine in some women is associated with changes in sex hormone levels. Many women suffer from increased frequency of migraine around the time of menses. Menstrual migraine (MM) may be more severe than migraine that occurs at other times of the cycle. The pathogenesis of MM is probably related to declining estrogen levels after exposure to high levels of the hormone for several days. The acute treatment of MM is similar to that of non-menstrually-related attacks. 5-HT(1B/1D) agonists (triptans), ergots, NSAIDs, or combination analgesics may be used, although the response to some drugs may not be as robust as that of non-menstrual attacks. Women who suffer from frequent or debilitating MM attacks may benefit from perimenstrual prophylaxis that can be either hormonal or non-hormonal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17685879     DOI: 10.1517/14656566.8.11.1605

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  4 in total

1.  Hormonal contraceptive options for women with headache: a review of the evidence.

Authors:  Andrea G Edlow; Deborah Bartz
Journal:  Rev Obstet Gynecol       Date:  2010

Review 2.  Estrogen-growth factor interactions and their contributions to neurological disorders.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Headache       Date:  2008-07       Impact factor: 5.887

Review 3.  The effect of migraine prophylaxis on migraine-related resource use and productivity.

Authors:  Miguel J A Láinez
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

4.  Influence of physiologic hormonal modification and of hormonal treatment in a patient with a history of migraine with aura.

Authors:  Ferdinando Maggioni; Antonio Palmieri; Michele Tropea; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2008-02-12       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.